130 related articles for article (PubMed ID: 22343194)
1. Influence of achieved low-density lipoprotein cholesterol level with atorvastatin therapy on stabilization of coronary plaques: sub-analysis of the TWINS study.
Okada K; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
Circ J; 2012; 76(5):1197-202. PubMed ID: 22343194
[TBL] [Abstract][Full Text] [Related]
2. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
[TBL] [Abstract][Full Text] [Related]
4. Plaque-stabilizing effect of atorvastatin is stronger for plaques evaluated as more unstable by angioscopy and intravenous ultrasound.
Hirayama A; Saito S; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Nanto S; Takazawa K; Kodama K
Circ J; 2011; 75(6):1448-54. PubMed ID: 21502706
[TBL] [Abstract][Full Text] [Related]
5. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
[TBL] [Abstract][Full Text] [Related]
6. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study.
Yokoyama M; Komiyama N; Courtney BK; Nakayama T; Namikawa S; Kuriyama N; Koizumi T; Nameki M; Fitzgerald PJ; Komuro I
Am Heart J; 2005 Aug; 150(2):287. PubMed ID: 16086932
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study.
Hiro T; Hirayama A; Ueda Y; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
J Cardiol; 2014 Dec; 64(6):501-7. PubMed ID: 24725763
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy.
Hirayama A; Saito S; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Nanto S; Takazawa K; Kodama K
Circ J; 2009 Apr; 73(4):718-25. PubMed ID: 19225206
[TBL] [Abstract][Full Text] [Related]
9. Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound.
Gao WQ; Feng QZ; Li YF; Li YX; Huang Y; Chen YM; Yang B; Lu CY
BMC Cardiovasc Disord; 2014 May; 14():60. PubMed ID: 24886532
[TBL] [Abstract][Full Text] [Related]
10. [Results of randomized study: intensive lipid lowering treatment stops coronary atherosclerosis].
MMW Fortschr Med; 2004 Mar; 146(13):64-5. PubMed ID: 15219142
[No Abstract] [Full Text] [Related]
11. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
[TBL] [Abstract][Full Text] [Related]
12. Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study.
Yamada T; Azuma A; Sasaki S; Sawada T; Matsubara H;
Circ J; 2007 Dec; 71(12):1845-50. PubMed ID: 18037734
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
14. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
15. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy.
Takano M; Mizuno K; Yokoyama S; Seimiya K; Ishibashi F; Okamatsu K; Uemura R
J Am Coll Cardiol; 2003 Aug; 42(4):680-6. PubMed ID: 12932601
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
[TBL] [Abstract][Full Text] [Related]
17. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
18. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
Ridker PM; Morrow DA; Rose LM; Rifai N; Cannon CP; Braunwald E
J Am Coll Cardiol; 2005 May; 45(10):1644-8. PubMed ID: 15893181
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia.
Bays HE; Averna M; Majul C; Muller-Wieland D; De Pellegrin A; Giezek H; Lee R; Lowe RS; Brudi P; Triscari J; Farnier M
Am J Cardiol; 2013 Dec; 112(12):1885-95. PubMed ID: 24063830
[TBL] [Abstract][Full Text] [Related]
20. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound--the TOGETHAR trial.
Kodama K; Komatsu S; Ueda Y; Takayama T; Yajima J; Nanto S; Matsuoka H; Saito S; Hirayama A
Circ J; 2010 Sep; 74(9):1922-8. PubMed ID: 20625215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
